LABP
Landos Biopharma, Inc. Common Stock
LABP
LABP
Delisted
LABP was delisted on the 23rd of May, 2024.
11 hedge funds and large institutions have $5.93M invested in Landos Biopharma, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
Holders
11
Holders Change
+3
Holders Change %
+37.5%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
TRCT
1
Tower Research Capital (TRC)
New York
|
$4.58K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
PA
1
Perceptive Advisors
New York
| $5.77M | 1,486,991 | – | – |
|
2
Macquarie Group
Sydney, NSW 2000,
Australia
| $57K | 14,718 | +14,718 | New |
|
3
Geode Capital Management
Boston,
Massachusetts
| $48.8K | 12,604 | +12,604 | New |
|
4
Renaissance Technologies
New York
| $40K | 10,260 | +10,260 | New |
|
5
Royal Bank of Canada
Toronto,
Ontario, Canada
| $5K | 1,209 | +597 | +98% |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $4.58K | 1,180 | -362 | -23% |
|
7
JPMorgan Chase & Co
New York
| $228 | 59 | – | – |
|
8
BlackRock
New York
| $163 | 42 | – | – |
|
9
UBS Group
Zurich,
Switzerland
| $144 | 37 | – | – |
|
10
Wells Fargo
San Francisco,
California
| $35 | 9 | – | – |
|
|
CFGS
11
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
12
Acadian Asset Management
Boston,
Massachusetts
| $0 | 134 | – | – |
|